Higher FT4 levels were associated with increased risks for knee OA prevalence, severity, and progression, especially among patients with greater joint loading.

Patients at WWL are experiencing life-changing care for the treatment of osteoarthritis and chronic knee-pain by using the Apos® device, a NICE recommended clinical innovation that is supported by the ...

Objective Glenohumeral (GH) osteoarthritis (OA) is the third most common large joint disease, after hip and knee OA. This ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

If walking is becoming difficult and physio isn’t working, cutting-edge treatments could be the next step. But which ones are ...

Studies suggest collagen supplementation may help improve conditions such as osteoarthritis, osteoporosis, sarcopenia, ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of ...

Aim This study investigated the prevalence and factors associated with pain and osteoarthritis (OA) at the hip and knee in Great Britain’s (GB) Olympians aged 40 and older. Methods This is a ...

An orthopaedic surgeon discusses how this approach helps alleviate pain caused by joint injuries and chronic conditions.

The "Cartilage Regeneration Market by Type, by Treatment Modality, by Application Site, by Surgical Procedure, by End-user, ...

Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.